Showing results (681-690 of 771) with videos related to

Sort By:
Pageof 78
Journal of Thrombosis and Haemostasis : JTH|July 30, 2013
Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonismS Nylander, E A Femia, M Scavone, et al.
European Urology|May 4, 2010
Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinenceGiacomo Novara, Walter Artibani, Matthew D Barber, et al.
Allergy|November 8, 2014
Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteasesA Gela, G Kasetty, S Jovic, et al.
Clinical Genetics|July 28, 1999
An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)U Ekström, M Abrahamson, C H Florén, et al.
European Journal of Endocrinology|March 30, 2012
Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-upD S Olsson, M Buchfelder, K Wiendieck, et al.
Gastroenterology|January 1, 1996
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
Inflammatory Bowel Diseases|August 29, 2000
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupE J Irvine, G R Greenberg, B G Feagan, et al.
The New England Journal of Medicine|September 29, 1994
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
Pharmaceutical Research|October 26, 2005
The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluidsEva M Persson, Ann-Sofie Gustafsson, Anders S Carlsson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trialGudmundur Johannsson, Pia Burman, Lena Wirén, et al.
Pageof 78